The Hill: Preparing for the next biosecurity threat
Paul Chaplin, co-chair of the Alliance for Biosecurity and president and CEO of Bavarian Nordic, and Elizabeth G. Posillico, co-chair of the Alliance for Biosecurity and president and CEO of Elusys Therapeutics

“…Unfortunately we live in a world in which the potential for a biological outbreak, natural or man-made, is ever-present. … We must, therefore, strive to be prepared for the most likely and the most disruptive potential threats. This is true at home and equally true around the globe. … Therefore, while we are encouraged by the [Obama] administration’s commitment to support new, innovative medical countermeasures, more needs to be done — including sustained and robust government investments — to better prepare for an attack or outbreak. Toward that end, Sens. Richard Burr (R-N.C.), Bob Casey (D-Pa.), and Lamar Alexander (R-Tenn.) introduced an amendment included in the final Senate Budget Resolution that endorses strengthening national security by fully funding the Project BioShield Special Reserve Fund through 2025…” (4/17).